One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Genetically engineered CAR T cells to hack prostate cancer TME
Maria Chiara MasoneÂÂ
doi : 10.1038/s41585-022-00599-w
Volume 19 Issue 5, May 2022
Predicting cancer outcomes after resection of high-risk RCC
Juliet A. Usher-Smith & Grant D. StewartA
Oligometastases: the art of providing metastases-directed therapy in prostate cancer
Fijs W. B. van Leeuwen & Henk G. van der PoelA
AI for prostate cancer diagnosis � hype or today’s reality?
Ali Bashashati & S. Larry GoldenbergA
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer
Udit Singhal, Ted A. Skolarus, John L. Gore, Matthew G. Parry, Ronald C. Chen, Julie Nossiter, Alan Paniagua-Cruz, Arvin K. George, Paul Cathcart, Jan van der Meulen & Daniela A. WittmannA
Recurrence mechanisms of non-muscle-invasive bladder cancer � a clinical perspective
Jeremy Yuen-Chun Teoh, Ashish M. Kamat, Peter C. Black, Petros Grivas, Shahrokh F. Shariat & Marek BabjukA
Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group
Valentina Capone, Nicola Persico, Alfredo Berrettini, St?¨phane Decramer, Erika Adalgisa De Marco, Diego De Palma, Alessandra Familiari, Wout Feitz, Maria Herthelius, Vytis Kazlauskas, Max Liebau, Gianantonio Manzoni, Michal Maternik, Giovanni Mosiello, Joost Peter Schanstra, Johan Vande Walle, Elke W?¼hl, Elisa Ylinen, Aleksandra Zurowska, Franz Schaefer & Giovanni MontiniA
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma
Rebecca A. Sager, Sarah J. Backe, Elham Ahanin, Garrett Smith, Imad Nsouli, Mark R. Woodford, Gennady Bratslavsky, Dimitra Bourboulia & Mehdi Mollapour
